Back to search

France· FR:60811559

ESKESIA 25 mg/mL, solution injectable/pour perfusion

A medicinal product containing chlorhydrate d'eskétamine, registered in France by INTERNATIONAL DRUG DEVELOPMENT.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedESKESIA 25 mg/mL, solution injectable…ATC—REGISTER NO.FR:60811559PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'ESKÉTAMINE
Manufacturer
INTERNATIONAL DRUG DEVELOPMENT
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400955073789
    10 ampoule(s) en verre de 2 ml
  • cip13
    3400955073796
    10 ampoule(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhydrate d'eskétamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhydrate d'eskétamine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Escetex, Eskelan
  • Belgium · Esketamine Kalceks, Vesierra
  • Germany · Esketamin, Esketamin Inresa
  • Denmark · Esketamine Orifarm, S-Ketamin Pfizer
  • Estonia · Esketex
  • Finland · Esketamine Kalceks, Esketamine Orifarm
  • United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
  • Croatia · Esgamda
  • Iceland · S-Ketamin Pfizer, Spravato
  • Liechtenstein · Spravato
  • Luxembourg · Vesierra
  • Latvia · Esketamine Kalceks
  • Netherlands · Esketamine Focus, Esketamine Idd
  • Norway · Ketanest, Sinmelan
  • Sweden · Esketamine Kalceks, Esketamine Orifarm
  • Slovenia · Esketamin Kalceks, Sinmelan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c4d1ad5-6962-4a54-b62a-e5ef1d9b694f
GET /v1/drugs/5c4d1ad5-6962-4a54-b62a-e5ef1d9b694f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60811559",
  "date_amm": "2020-05-18",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE D'ESKÉTAMINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable ou pour perfusion",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about chlorhydrate d'eskétamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.